Sort by
Search results
ADP Assay for Platelet Aggregation
Investigation of congenital (e.g. Glanzmann’s thrombasthenia, Bernard-Soulier, gray platelet syndrome) or acquired thrombopathy (e.g., myelodisplasic or myeloproliferative syndrome, Waldenström’s disease, multiple myeloma, hepatic or renal failure). Follow-up of patients treated with antiplatelet drugs such as aspirin, thienopyridines, abciximab and other NSAIDs and GPIIb/IIIa inhibitors.
5D Protein Stabilizer
The 5D Protein Stabilizer can be used for protein stabilization, in lyophilized formulations or in liquid solutions, during urea, ethanol or heat treatment. Applications as active sites blocker in ELISAs or on coated surfaces.
5-PLASMA α2-Antiplasmin Deficient Plasma, frozen
For any in vitro protocol or research study where a source of human α2-antiplasmin deficient plasma is required.
5-PLASMA vWF Deficient Plasma, frozen
For any in vitro protocol or research study where a source of human vWF deficient plasma is required.
5-PLASMA tPA Deficient Plasma, frozen
For all in-vitro-analyses that require human tPA deficient plasma.
5-PLASMA tPA & PAI-1 Deficient Plasma, frozen
For all in-vitro-analyses that require human tPA/PAI-1 deficient plasma.
5-PLASMA TAFI Deficient Plasma, frozen
For any in vitro protocol or research study where a source of human TAFI deficient plasma is required.
5-PLASMA Protein S Deficient Plasma, frozen
For any in vitro protocol or research study where a source of human protein S deficient plasma is required.
5-PLASMA Protein C Inhibitor Deficient Plasma, frozen
For any in vitro protocol or research study where a source of human protein C inhibitor deficient plasma is required.
5-PLASMA Protein C Deficient Plasma, frozen
For any in vitro protocol or research study where a source of human protein C deficient plasma is required.